Tourmaline Bio Inc (NAS:TRML)
$ 14.5 -1.27 (-8.05%) Market Cap: 371.87 Mil Enterprise Value: 169.34 Mil PE Ratio: 0 PB Ratio: 1.44 GF Score: 24/100